Morgan Stanley’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75M | Sell |
|
|||||
|
2025
Q1 | $127M | Buy |
|
|||||
|
2024
Q4 | $67.4M | Sell |
|
|||||
|
2024
Q3 | $57.2M | Buy |
|
|||||
|
2024
Q2 | $61.6M | Sell |
|
|||||
|
2024
Q1 | $77.1M | Sell |
|
|||||
|
2023
Q4 | $70.3M | Buy |
|
|||||
|
2023
Q3 | $25.1M | Buy |
|
|||||
|
2023
Q2 | $17.2M | Sell |
|
|||||
|
2023
Q1 | $35.8M | Buy |
|
|||||
|
2022
Q4 | $31.8M | Buy |
|
|||||
|
2022
Q3 | $3.84M | Sell |
|
|||||
|
2022
Q2 | $5.94M | Sell |
|
|||||
|
2022
Q1 | $9.62M | Buy |
|
|||||
|
2021
Q4 | $4.1M | Sell |
|
|||||
|
2021
Q3 | $5.44M | Sell |
|
|||||
|
2021
Q2 | $9.13M | Sell |
|
|||||
|
2021
Q1 | $30.8M | Buy |
|
|||||
|
2020
Q4 | $5.73M | Buy |
|
|||||
|
2020
Q3 | $3.33M | Buy |
|
|||||
|
2020
Q2 | $3.02M | Buy |
|
|||||
|
2020
Q1 | $1.65M | Buy |
|
|||||
|
2019
Q4 | $2.16M | Sell |
|
|||||
|
2019
Q3 | $3.02M | Buy |
|
|||||
|
2019
Q2 | $1.52M | Buy |
|
|||||
|
2019
Q1 | $1.68M | Sell |
|
|||||
|
2018
Q4 | $7.21M | Buy |
|
|||||
|
2018
Q3 | $4.64M | Sell |
|
|||||
|
2018
Q2 | $6.65M | Buy |
|
|||||
|
2018
Q1 | $1.44M | Buy |
|
|||||
|
2017
Q4 | $928K | Buy |
|
|||||
|
2017
Q3 | $255K | Buy |
|
|||||
|
2017
Q2 | $63K | Buy |
|
|||||
|
2017
Q1 | $33K | Buy |
|
|||||
|
2016
Q4 | $5K | Buy |
|
|||||
|
2016
Q3 | $3K | Sell |
|
|||||
|
2016
Q2 | $3K | Sell |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $14K | Sell |
|
|||||
|
2015
Q3 | $74K | Sell |
|
|||||
|
2015
Q2 | $121K | Sell |
|
|||||
|
2015
Q1 | $371K | Sell |
|
|||||
|
2014
Q4 | $1.67M | Buy |
|
|||||
|
2014
Q3 | $919K | Buy |
|
|||||
|
2014
Q2 | $460K | Buy |
|
|||||
|
2014
Q1 | $361K | Buy |
|
|||||
|
2013
Q4 | $337K | Buy |
|
|||||
|
2013
Q3 | $272K | Sell |
|
|||||
|
2013
Q2 | $760K | Buy |
|